Navigation Links
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
Date:8/19/2007

epted by the market, including the risk that these products will not be competitive with products offered by other companies; and (2) other factors that might be described from time to time in Applera's filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Applera does not undertake any duty to update this information, including any forward-looking statements, unless required by law.

About Abbott's Molecular Diagnostics Business

Abbott Molecular, a division of Abbott based in Des Plaines, Ill., is an emerging leader in molecular diagnostics -- the analysis of DNA, RNA and proteins at the molecular level. Abbott Molecular's instruments and tests provide physicians with critical information based on the early detection of pathogens and subtle, but key changes in patients' genes and chromosomes. They help physicians diagnose disease and infections earlier, select appropriate therapies and monitor disease progression. In addition to the RealTime HIV-1 viral load test and the Abbott m2000, Abbott Molecular's portfolio of products also includes innovative genomic tests for chromosome changes associated with congenital disorders and cancer, including the PathVysion(R) HER-2 DNA Probe Kit, a test used to help select women with breast cancer who could benefit from Herceptin(R) therapy, and UroVysion(TM), which detects genetic changes in bladder cells for aiding in the diagnosis of bladder cancer in patients with hematuria (blood in the urine) and for monitoring bladder cancer recurrence.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available at the company's Web site
'/>"/>

SOURCE Abbott

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The potential of the pulmonary ... therapeutic agents has been receiving undeniable attention with the ... promise. The crucial formulation considerations for orally inhaled products ... major role in the efficiency of pulmonary delivery, and ... new formulation techniques and devices in recent years. ...
(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... (CellCyte) (OTC Bulletin Board: CCYG) has selected the,Cardiovascular ... St. Louis to perform a study to further ... is to investigate the efficiency of,CellCyte,s glycoprotein products ... "We look forward to working with the ...
... University of,California San Diego, reported today at the American ... on the use of a,new technology, Neucrylate(TM), to treat ... developed by Valor Medical, a San Diego, CA,medical device ... to,date the accumulated patient implant times have reached 1400 ...
Cached Medicine Technology:CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model 2CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model 3
(Date:5/24/2013)... 2013 This week is National EMS ... efforts to provide the best emergency care and to ... week is also to educate the public that all ... Citizens are the first link, and a very important ... CPR after a cardiac arrest can triple a victim’s ...
(Date:5/24/2013)... hospitalized for heart failure appear to have better odds ... the morning, a new study finds. Death rates ... patients admitted in January, on Fridays and overnight, according ... findings Saturday in Portugal at the annual meeting of ... Cardiology. "The fact that patients admitted right ...
(Date:5/24/2013)... KC and Monica Craichy, Founders of Living Fuel, Inc ... Kyle and Austin Craichy, will be kiteboarding with members of ... , KC Craichy said he is excited to be involved ... that virtually everyone who planned to be involved is going ... meet at Matheson Hammock Park and Beach in Miami at ...
(Date:5/24/2013)... News) -- New research suggests a link between ... insomnia. Every additional hour someone with insomnia ... in the likelihood of moderate or high risk ... of Pennsylvania. "We were surprised by ... and suicide risk," study author, Linden Oliver, clinical ...
(Date:5/24/2013)... OR (PRWEB) May 24, 2013 ... Sustainable Cards, major competitors in sustainable card material, ... of using forest materials as a sustainable gift ... is to identify industry challenges and increase education ... card programs to support the reduction of carbon ...
Breaking Medicine News(10 mins):Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3
... -- How best to alleviate chronic pain, a leading ... both patients and their doctors. , A review ... June 2008 issue of the Journal of General Internal ... therapies to treat pain have advantages and disadvantages, researchers ...
... Week, June 9-13, National Leaders Convene to ... The following media,advisory was issued today by ... http://www.newscom.com/cgi-bin/prnh/20060801/CGTU009LOGO-a ), WHAT:, HIMSS ... June 9-10,2008. The Healthcare Information and Management Systems ...
... wear head protection, study says , , THURSDAY, June ... should wear headgear on the field to protect them ... , At the very least, players should consider wearing ... acknowledges that changing the culture of baseball may be ...
... Robust Pipelines Across Seven MD&D Franchises Poised to Deliver Innovation ... ... on Superior Science and Technology, NEW BRUNSWICK, N.J., June 5 ... at a,meeting with the investment community today, focusing on the strengths,strategies and ...
... Regional Medical,Foundation (SRMF) announces that its Vacaville care ... tool in screening for breast,cancer., Digital mammography, ... of the,most effective weapons in the fight against ... image quality is superior, with at least a ...
... out of five,disability income insurance claimants are satisfied ... by Harris Interactive on behalf of,America,s Health Insurance ... "Disability insurers are providing valuable income protection ... needs of disabled,workers," said Karen Ignagni, President and ...
Cached Medicine News:Health News:How best to treat chronic pain? The jury is still out 2Health News:HIMSS Summit08 and Advocacy Day 2Health News:Batted Balls Threaten High School Baseball Players 2Health News:Batted Balls Threaten High School Baseball Players 3Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 2Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 3Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 4Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 5Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 6Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 7Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 8Health News:Advanced Digital Mammography System Comes to Vacaville 2Health News:Four Out of Five Disability Income Insurance Claimants are Satisfied With Their Policy 2Health News:Four Out of Five Disability Income Insurance Claimants are Satisfied With Their Policy 3
... Total Knee System provides the adaptability surgeons ... patient. Not the other way around. The ... inserts and patellar components allow surgeons to ... you do it all with one instrument ...
... new implant. It's a new material, exclusively ... can be greatly reduced . The nickel ... of the nickel-sensitive patient. Hardness, lubricity and ... is available in our two already proven ...
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
Cementless hip system...
Medicine Products: